InvestorsHub Logo

BORN AGAIN

05/22/12 5:00 PM

#232262 RE: Nilbud #232260

its on my bar and its a time saver dude

j$tops

05/22/12 6:52 PM

#232273 RE: Nilbud #232260

Can't wait for the chrome version my friend!!!

Here it is!! The Biggest Thing For Stock Traders Since The Introduction of Level 2!!

Penny Stock Tweets Brings you the World’s First Stock Traders Toolbar – Download it Now for FREE http://pennystocktweets.com/pages/toolbar

This is the Firefox version – Internet Explorer version will follow in about two weeks, followed by the Google Chrome version.
After you download it, please post your reaction here.

WhisperingEye

05/22/12 9:14 PM

#232285 RE: Nilbud #232260

$Penny Stock Tweets THis place is awsome!

OCKHAM'S RAZOR

05/23/12 5:18 PM

#232659 RE: Nilbud #232260

BIG DAYS for TMEN, FROI, EMWW

Big volume surges

TMEN 2.5M+
volume avg 10 day is 70k

FROI 711k+
volume avg 10 day is 130k

EMWW 2.1M volumw avg 10 day is 600k

marirstk

05/28/12 8:07 PM

#234080 RE: Nilbud #232260

Are you following $EGT?

Psionicmatrix has 2.0 $ dollar target and i have 1.75-2.00$ target in the coming sessions.

$EGT closed on Friday @ 0.90 (20DMA) and traded over 700,000 shares.


http://www.barchart.com/cheatsheet.php?sym=EGT

Added 250 machines to Sokha resort.

Dreamland Pailin Casino opened on May 9th 2012.

Dreamland Poippet and Kampot casinos are opening soon in 2012.

OCKHAM'S RAZOR

05/30/12 5:08 PM

#234913 RE: Nilbud #232260

YGRENE's FEATURED PROGRAM is SACREMENTO ~!!!!

Assembled by the Carbon War Room, Ygrene leads "The Commercial PACE Consortium" a coalition, of leading financial, energy efficiency and climate change organizations to deliver no-cost, turnkey PACE financing on behalf of municipal governments.

Source: PR Newswire (http://s.tt/1bEq5)

http://ygrene.us/districts


OCTI & YGRENE connection link:

http://finance.yahoo.com/news/Octus-Joins-Ygrene-Energy-iw-326278887.html?x=0

22M float
49% insider ownership

Abondanceinvest

06/04/12 8:37 AM

#236442 RE: Nilbud #232260

Gm Nibud,BISU Huge winner in June!!!!!!!multi-baggger!!!!!!start this week..

mick

06/14/12 2:27 PM

#240172 RE: Nilbud #232260

VOLUME ALERT! maybe tweet ACYD nice breakout formation starting today.

*W* almost completed.



Gallery View
http://stockcharts.com/freecharts/gallery.html?ACYD

http://charts.insidestocks.com/procal.asp?sym=ACYD





mick

06/26/12 11:32 AM

#243441 RE: Nilbud #232260

just bud, germany announcement/we will not share the debt... there will be no euro bond.

europe cooked?

oops she said in her lifetime.

~ Blue ~

06/29/12 2:21 AM

#244320 RE: Nilbud #232260

~IMDS FDA stock, 35 PATENTS DD with links~


Scientific American: IMDS CTML-New Light on Breast Cancer

By Kelli A. Miller

Computed tomography laser mammography scan A LARGE AREA of suspicious new blood-vessel growth supporting a cancer tumor is clear in an image made with computed tomography laser mammography (CTLM).

CTLM gives radiologists a colorful 3-D cross-sectional view of each breast. The bright green and white globes conjure the image of a lime Jell-O salad filled with fruit.

"We can look through the breast from the front, the side, the back and all the way through," explains Eric Milne, chief radiologist for Imaging Diagnostic Systems, Inc. The company is currently seeking approval by the U.S. Food and Drug Administration (FDA) as an adjunct to mammography. It plans to eventually push for the technique's use as a screening tool.

The CTLM test, which is expected to cost patients about $150, revealed that Conlan's most recent lump was much larger than x-rays indicated, prompting her doctor to recommend a biopsy.

Cutting Back on Biopsies

Millions of dollars are spent each year on breast biopsies, the majority of which reveal that nothing is wrong. Experts say more informative imaging could dramatically reduce the number of unnecessary procedures.

http://www.scientificamerican.com/article.cfm?id=new-light-on-breast-cance

------------------------------------------------------------------

1) IMDS, fully reporting OTCQB company

http://www.otcmarkets.com/stock/IMDS/company-info


2) Imaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company. The Company is engaged in the development and testing of a Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM). As of June 30, 2010, IDSI was in the process of commercializing the CTLM in certain international markets where approvals to market have been secured although CTLM is not yet approved for sale in the United States. The CTLM system is a CT-like scanner, but its energy source is a laser beam and not ionizing x-radiation such as is used in conventional x-ray mammography or CT scanners. IDSI’s Laser Imager for Lab Animals (LILA) program is an optical helical micro-CT scanner in a third-generation configuration.

http://www.imds.com/


3) Watch Video: A Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM).

http://www.imds.com/imaging-diagnostics/IDSI-Video.php

IMDS link - CT Laser Mammography http://eurolifecare.com/pdf/Product%20Booklet.pdf

Another link http://www.edomed.cz/download/ctlm_datasheet.pdf

~~~~~~~~~~ PATENTS, CERTIFICATES, DISTRIBUTORS ~~~~~~~~~~~~~

4) IMDS has 35 patents, twenty (20) US patents for the various components and technology with an additional fifteen (15) international patents.

http://www.imds.com/imaging-diagnostics/Corporate-Frequently-Asked-Questions.php

http://www.imds.com/ctlm/CTLM-Patents.php

http://www.patentstorm.us/search/advanced.html?ptn_no=&inv_nm=&ttl=&isdt_start=&isdt_end=&fldt_start=&fldt_end=&ptn_txt=&asg_nm=Imaging+Diagnostic+Systems%2C+Inc.&atn=&examiner=&cls=&int_cls=&doc_type%5B%5D=0&doc_type%5B%5D=1&sort=0


5) IMDS got ISO-13485 certification

--- CE Marking (accepted 32 countries in Europe)

http://www.prnewswire.co.uk/news-releases/imaging-diagnostic-receives-ce-marking-approval-154457395.html

CE Marking countries list

http://export.gov/cemark/eg_main_017269.asp

--- China SFDA certification

--- Canada Medical Device License-CMDCAS

www.imds.com/ctlm/Regulatory-Status.php


6) VITAL FDA LEG: FDA gave export certification to IMDS for enabling sales in international markets.

http://www.imds.com/ctlm/Regulatory-Status.php

7) IMDS has distributors in 25 countries

http://www.imds.com/ctlm/CTLM-Distributors.php


~~~~~~~~~~~~~~~~~~~ FDA REGULATORY STATUS ~~~~~~~~~~~~~~~~~~~

7) IMDS- FDA Regulatory Status

As of November 2010, IDSI has submitted a 510(k) application to the FDA. With this submission, the company moves forward in the process of seeking marketing clearance for its innovative breast imaging device, the CTLM system. The Company intends to pursue a rigorous clinical program to discover and commercialize the envisioned applications.

http://www.imds.com/ctlm/Regulatory-Status.php


8) As of Feb 2012, IMDS Securing FDA Approval for DOT


Feb 09, 2012 (Close-Up Media via COMTEX) --
Imaging Diagnostic Systems, Inc., ("IDSI") a provider of laser based Diffuse Optical Tomography (DOT) for breast cancer detection, announced that it remains fully committed to securing FDA approval. The company is in the process of submitting a PMA application to the FDA.
Linda Grable, Chairman and CEO of IDSI said "After years of developing a truly unique and non-invasive breast imaging technology, we are pleased to be recognized as "Diffuse Optical Tomography." In addition, as possibly the first DOT breast imaging modality to seek FDA approval, we are completely dedicated to meeting all of the FDA requirements as quickly as possible."
Mrs. Grable goes on to state that: "IDSI"s management team remains focused on providing shareholder value. Management is presently investigating several long term financing strategies that will both maintain and increase shareholder value and achieve our FDA objectives. IDSI understands that there have been some unidentified and uncontrollable forces putting pressure on our stock price. IDSI is a late stage research and development company that currently has various international registrations and approvals. CTLM (Computed Tomography Laser Mammography) is being used daily by doctors in those markets as a non invasive breast imaging modality. Our ultimate goal is to provide this technology and its benefits to women in the United States."
Dr. S. Ponder Director, Advanced Development for IDSI said "We continue to be encouraged by our clinical study results. Especially, when dealing with heterogeneous and extremely dense breasts. We have been able to demonstrate that CTLM increases detection sensitivity especially in Extremely Dense Breast (BIRADS classification), when compared to x-ray based mammography. The CTLM examination is performed without breast compression, x-ray radiation, or contrast injections. In addition, the non-invasive and non-radiation patient benefits of CTLM could become a very important future clinical benefit especially now that many breast screening programs are under significant scrutiny."
((Comments on this story may be sent to health@closeupmedia.com))

Copyright Close-Up Media, Inc. 2012. All Rights reserved

http://www.imds.com/news/

FDA's website: IMAGING DIAGNOSTIC SYSTEMS, INC. CTLM SYSTEM MODEL 1020 COMPUTED TOMOGRAPHY LASER MAMMOGRAPHY Back to Search Results

http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=1834512&utm_campaign=Google2&utm_source=fdaSearch&utm_medium=website&utm_term=Imaging%20Diagnostic%20Systems,%20Inc.&utm_content=3


9) IMDS Clinical Case studies has been made by those hospitals and universities

Charite Mitte University Hospital
Charles University
European Institute of Oncology
Friendship Catholic University
Gazi University
Gliwice Poland
SAQR Hospital
Udine University


http://www.imds.com/clinical/CTLM-Case-Studies.php


~~~~~~~~~~~~~~~~~~ IMDS MANAGEMENT TEAM ~~~~~~~~~~~

10) Linda Grable - Chairman of The Board, CEO & Director

Mrs. Grable is a Founder and significant shareholder of Imaging Diagnostic Systems, Inc.

A graduate of Ohio State University with a BA degree in Journalism and Marketing, she had over 30 years of experience in financial negotiations for both medical and real estate development businesses. In addition, she had over 20 years of executive experience in the medical device industry, for both sales and marketing in the U.S. and foreign countries.

Allan Schwartz - Executive Vice-President, CFO and Co-Founder - Director
Mr. Schwartz joined IDSI in 1994. Mr. Schwartz is the Chief Financial Officer and Executive Vice-President. He has a broad range of management, marketing, engineering, and business development experience. Mr. Schwartz is the developer of the Chronometric Trading System for analyzing stock market trends using neural networks. He also pre-engineered homes for export to Belize, Central America for S.E Enterprises of Miami, Florida. In 1991 he formed Tron Industries, Inc. for the development of low-voltage and self-contained battery powered portable neon products. He is a graduate of C.W. Post College of Long Island University with a B.S. in Business Administration.

Deborah O'Brien - Senior Vice-President

Deborah O'Brien was appointed Senior Vice President on September 15, 2003. Ms. O'Brien joined IDSI in 1995. She has held the positions of Director of Investor Relations, Vice President of Corporate Communications and most recently, since September 2001, Vice President of Business Development. Her responsibilities included developing and executing a strategic corporate communications campaign, managing internal communications and IDSI public relations. Ms. O'Brien developed and established a program of consumer and industry awareness of the CTLM System via a media outreach which targeted industry publications, national network television, radio, nationally-circulated publications and high traffic internet sites.

Ms. O'Brien is responsible for IDSI's FDA process including clinical data collection, preparation, filings, and interface with the FDA. Prior to joining IDSI, she worked for seven years in the financial arena, managing investor accounts, and in the medical device industry, marketing medical equipment. Ms. O'Brien began her career in the mortgage loan industry as an account executive with Citibank.

David Schmidt – Director

On August 1, 2011, Mr. Schmidt was appointed by our Board of Directors to serve on the Board. Mr. Schmidt has served since 2008 as an independent consultant advising companies in the chemicals and materials, healthcare, and alternate energy industries regarding strategic marketing and execution services. From 2004 until 2008, Mr. Schmidt served as the Manager of Commercial Excellence and the Strategic Marketing and Business Development Manager at Honeywell International, Inc., Morristown, NJ. From 2000 until 2003, Mr. Schmidt served as a Senior Director and Chief Operations Officer of Plasmion Corporation, Inc., Hoboken, NJ. Mr. Schmidt has also served in management and officer positions at Film Specialties, Inc., Hillsborough, NJ, from 1993 until 2000; at Hydromer, Inc., Whitehouse, NJ, an invasive medical device specialty coatings company from 1989 until 1992; and at ROI Group, Inc., Parsippany, NJ, from 1986 until 1988. Mr. Schmidt earned his bachelor of science in business and economics from Lehigh University.

http://www.imds.com/imaging-diagnostics/Directors-Management.php


CFO Michael W. Addley, started in Jan 2012

Mr. Addley is an executive with decades of experience leading domestic and international medical device operations. The Company believes that his extensive experience launching "high-tech" medical devices and new procedures will play a valuable role in the Company's efforts to pursue FDA marketing clearance. Most recently, from 2006 - 2008, Mr. Addley served as Vice-President/New Business Development of Polar Technics Ltd. (Australia), and since 2008 has provided consulting services to medical device manufacturers, including the Company, through his consulting firm, Addley International Corp., London, Ontario.

http://www.sec.gov/Archives/edgar/data/790652/000079065211000051/form8-k_120911.htm

Dr. Jose Cisneros, Head of Clinical Research for IMDS-

Imaging Diagnostic Systems, has been invited to present; “New Imaging Modalities for Breast Cancer” featuring CT Laser Breast Imaging (CTLM). Dr Cisneros is a radiologist and biomedical engineer, with more than 30 years of clinical investigate and preparation in healthcare technology. His area of skill is in Biomedical Imaging, Digital imaging systems, evidence Ultrasound and Magnetic Resonance Imaging. He was a highbrow at the Jefferson Ultrasound Research and Education Institute in Philadelphia and previous to fasten IDSI he worked as a clinical operative for Picker International Inc.

http://forhotelsflorida.com/page/37/


11) IMDS has 18 employees

http://www.google.ca/finance?q=imds


~~~~~~~~~~~ REVENUE, SHARE STRUCTURE ~~~~~~~~~~

12) IMDS revenue increased 480% in the first quarter of 2012 when you compare first quarter of 2011.

2012(first quarter): 211,720 dollars

2011(first quarter): 36,515 dollars

PAGE 4

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8632452


13) IMDS O/S 2.4 billion, a/s 4 billion

http://www.otcmarkets.com/stock/IMDS/company-info


14) The company requested SEC to Cancel 740 million shares recently

SEC FILINGS OUT ON MAY 17, 2012

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8038247

200 mil

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8163875

180 mil

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8204806

180 mil

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8272181

180 mil

http://ih.advfn.com/p.php?pid=nmona&article=52462072

http://ih.advfn.com/p.php?pid=nmona&article=52462084

http://ih.advfn.com/p.php?pid=nmona&article=52462089

http://ih.advfn.com/p.php?pid=nmona&article=52462100


15) IMDS- insiders hold 52 million of Outstanding shares


Name and Address of Beneficial Owner

Number of Shares of Common Stock Owned Beneficially(1)(2)

% of Outstanding Shares of Common Stock

Number of Shares of Series Q Preferred Owned

% of Outstanding Series Q Preferred Stock


Linda B. Grable

27,510,274(3)

1.56%

51

100%
5307 NW 35th Terrace

Fort Lauderdale, FL 33309


Allan L. Schwartz

16,255,520(4)

0.92%

5307 NW 35th Terrace

Fort Lauderdale, FL 33309


Deborah O’Brien

8,412,000(5)

0.48%

5307 NW 35th Terrace

Fort Lauderdale, FL 33309


David Schmidt

187,500(6)

0.01%

5307 NW 35th Terrace

Fort Lauderdale, FL 33309


All officers and directors

52,365,294(7)

2.97%

51

100%
as a group (4 persons)



~~~~~~~~~~~ MOST RECENT NEWS, PUBLICATIONS ~~~~~~~~~~~~~~

16) IMDS'S giant Distributor JAPAN Shimadzu

Imaging Diagnostic Signs Shimadzu Medical to Market Its CTLM(R) Laser Breast Imaging Device in Australia, New Zealand and the Pacific Islands


FORT LAUDERDALE, FL, May 14, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. (OTCBB: IMDS), a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Shimadzu Medical to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Australia, New Zealand and the Pacific Islands.

"This strategic move follows in line with our vision to be in the forefront of innovative technologies that will further enhance our business. The Directors of Shimadzu Corporation unanimously agreed that the CTLM(R) system could heighten our image in the breast imaging realm. IDSI has developed a high quality innovative breast imaging product that will expand our product range. Shimadzu is well positioned to provide ongoing sales, service and support for the CTLM given our history and expertise in the medical device arena. We are excited to make this innovative technology available to women in Australia, New Zealand and the Pacific Islands," commented Nick Mascoulis, General Manager/Shimadzu Medical Systems (Oceania) P/L.

Shimadzu Medical Systems (Oceania) Pty Ltd is an Australasian subsidiary of Shimadzu Corporation, Kyoto, Japan. Shimadzu's goal is to support a healthy, comfortable living for all people. They have strived to contribute to people's health and well-being since their inception in 1875. Shimadzu focuses on the development of "molecular imaging technology" to enable detection of subtle symptoms before the onset of full-blown diseases.

Linda Grable, CEO of Imaging Diagnostic Systems, Inc., states, "IDSI is very excited to appoint Shimadzu Corporation, a leader of global technologies, as the distributor in Australia, New Zealand and the Pacific Islands. We are eager to work with Shimadzu to make CTLM(R) available to women in that part of the globe."

17) MAREEN GROUP KUWAIT DISTRIBUTOR

FORT LAUDERDALE, FL, May 22, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. IMDS 0.00% , a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Mareen Group to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Kuwait.

"Mareen Group is honored to present the CTLM(R) to the women of Kuwait. We are eager to support the imaging needs of patients through this dignified and innovative laser breast imaging modality," commented Ahmad Abdulrahman, General Manager of Mareen Group.

Mareen Group is a Medical & Pharmaceutical distribution company well established and based in Kuwait. They have been in operation since 1998, proudly providing various medical and healthcare institutions within Kuwait and the surrounding areas with advanced medical equipment and pharmaceuticals from across the globe. The philosophy of Mareen Group has always been to build close ties with their customers by supporting their every need with prompt professional service and support.

Imaging Diagnostic's CEO, Linda Grable, states, "IDSI is delighted to assign Mareen Group, a well established medical company in Kuwait, as our new distributor. The women in Kuwait will hopefully benefit from CTLM(R)'s unique and discrete breast imaging process to aid in the diagnosis and management of breast abnormalities. We are enthusiastic to work with Mareen Group to make the CTLM(R), a non-invasive alternative, accessible to women in Kuwait."

-----------

~~~Hundreds of thousands of Hospitals and Clinics in the world. Almost all of them are potential customers of IMDS.

~~~~ With FDA update PENNYLAND, with FDA approval DOLLARLAND, IMO.

~~~ IMDS is an sleeping giant, undervalued solid company, Read, check the links..make your own decision





~Blue~

20 CTLM sales agreement, $9$ million REVENUE

RECENT 10Q, March 31, 2012

In December 2011, we announced that we signed an exclusive distribution agreement with ID Matrix Systems to market and sell our CTLM® systems to private and government hospitals and private imaging centers throughout China and Hong Kong.


The agreement stipulates that ID Matrix must purchase a minimum of 15 CTLM® systems within the first year of the contract along with a 50% deposit with each order to remain our exclusive distributor for the territories.


RECENT 10Q PAGE 66

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8632452

+++++++++++++++ ADD THIS +++++++++++++++++++


First of Five Systems sold to Mexico


First of Five Systems to Be Installed
Wednesday, November 23rd, 2011


FORT LAUDERDALE, Fla., November 3, 2011–(BUSINESS WIRE)– Imaging Diagnostic Systems, Inc., (OTCBB:IMDS.OB – News), a pioneer in laser optical breast imaging announced today that it has sold the first system of five ordered to be installed in Mexico. The system is scheduled to be installed during the third week of December. The purchase order was made through its exclusive distributor Kepter Internacional for Estados Unidos Mexicanos.

Kepter Internacional is scheduled to hold a presentation featuring the CTLM system and announcing its arrival to Mexico in January in front of the COFEPRIS (Health Ministry) of Mexico. Kepter Internacional is the exclusive agent for Imaging Diagnostic Systems, authorized to promote, distribute and service the CT Laser Mammography (CTLM) System throughout Mexico.

http://www.imds.com/news/2011/11


=================================

TOTAL 20 CTLM sales agreement

IMDS MARKETING DIRECTOR RICHARD GRABLE SAYS CTLM PRICE 495,000 DOLLARS, confirmed many times.

The company Phone: 954-581-9800 easy to confirm. call him


------------------------

LETS DO THE MATH:

20 CTLM x 495,000 DOLLARS EACH= 9.9 MILLION DOLLARS..


===============================================

HERE IS THE SOURCE OF MONEY.

Kooka_Duke

07/03/12 1:14 PM

#245377 RE: Nilbud #232260

""Happy 4th Of July Players""....Have a Safe Hot Fun In The Sun Holiday.....

~ Blue ~

07/04/12 12:14 AM

#245417 RE: Nilbud #232260

IMDS- Scientific American: New Light on Breast Cancer

By Kelli A. Miller

Computed tomography laser mammography scan A LARGE AREA of suspicious new blood-vessel growth supporting a cancer tumor is clear in an image made with computed tomography laser mammography (CTLM).

CTLM gives radiologists a colorful 3-D cross-sectional view of each breast. The bright green and white globes conjure the image of a lime Jell-O salad filled with fruit.

"We can look through the breast from the front, the side, the back and all the way through," explains Eric Milne, chief radiologist for Imaging Diagnostic Systems, Inc. The company is currently seeking approval by the U.S. Food and Drug Administration (FDA) as an adjunct to mammography. It plans to eventually push for the technique's use as a screening tool.

The CTLM test, which is expected to cost patients about $150, revealed that Conlan's most recent lump was much larger than x-rays indicated, prompting her doctor to recommend a biopsy.

Cutting Back on Biopsies

Millions of dollars are spent each year on breast biopsies, the majority of which reveal that nothing is wrong. Experts say more informative imaging could dramatically reduce the number of unnecessary procedures.

http://www.scientificamerican.com/article.cfm?id=new-light-on-breast-cance

mick

07/04/12 12:59 PM

#245536 RE: Nilbud #232260

happy fourth to all...usually ihub has title above 'HAPPY 4TH OF JULY!

thank you for all you do for us.

~ Blue ~

07/04/12 3:09 PM

#245554 RE: Nilbud #232260

IMDS(.0004) has FDA export Certification

for enabling CTLM sales in international markets. The company sold 18 CTLM and made agreement to sell 15 CTLM to China and 5 of them to Mexico this year.

http://www.imds.com/ctlm/Regulatory-Status.php

Kooka_Duke

07/12/12 12:15 PM

#248332 RE: Nilbud #232260

""Explosive DD Here On SAGD My Mega Gold Play...<<<<<

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77437331

Insiders That Own Most Of The Float Which By The Way Is 71Milly!

http://www.secform4.com/insider-trading/1351765.htm

~ Blue ~

07/12/12 9:04 PM

#248550 RE: Nilbud #232260

IMDS(.0019) has CE Marking-accepted 32 countries in Europe

http://www.prnewswire.co.uk/news-releases/imaging-diagnostic-receives-ce-marking-approval-154457395.html

CE Marking countries list

http://export.gov/cemark/eg_main_017269.asp

www.imds.com/ctlm/Regulatory-Status.php

Mick Dodge

07/12/12 11:17 PM

#248572 RE: Nilbud #232260

CTDTCheck this chart out!

~ Blue ~

07/14/12 10:36 PM

#249408 RE: Nilbud #232260

IMDS(.0015)~~CTLM scanning for life Video http://www.imds.com/imaging-diagnostics/IDSI-Video.php

~ Blue ~

07/17/12 1:00 AM

#250221 RE: Nilbud #232260

IMDS(.0018)- Securing FDA Approval for DOT

Feb 09, 2012 (Close-Up Media via COMTEX) --

Imaging Diagnostic Systems, Inc., ("IDSI") a provider of laser based Diffuse Optical Tomography (DOT) for breast cancer detection, announced that it remains fully committed to securing FDA approval. The company is in the process of submitting a PMA application to the FDA.

Linda Grable, Chairman and CEO of IDSI said "After years of developing a truly unique and non-invasive breast imaging technology, we are pleased to be recognized as "Diffuse Optical Tomography." In addition, as possibly the first DOT breast imaging modality to seek FDA approval, we are completely dedicated to meeting all of the FDA requirements as quickly as possible."

Mrs. Grable goes on to state that: "IDSI"s management team remains focused on providing shareholder value. Management is presently investigating several long term financing strategies that will both maintain and increase shareholder value and achieve our FDA objectives. IDSI understands that there have been some unidentified and uncontrollable forces putting pressure on our stock price. IDSI is a late stage research and development company that currently has various international registrations and approvals. CTLM (Computed Tomography Laser Mammography) is being used daily by doctors in those markets as a non invasive breast imaging modality. Our ultimate goal is to provide this technology and its benefits to women in the United States."

Dr. S. Ponder Director, Advanced Development for IDSI said "We continue to be encouraged by our clinical study results. Especially, when dealing with heterogeneous and extremely dense breasts. We have been able to demonstrate that CTLM increases detection sensitivity especially in Extremely Dense Breast (BIRADS classification), when compared to x-ray based mammography. The CTLM examination is performed without breast compression, x-ray radiation, or contrast injections. In addition, the non-invasive and non-radiation patient benefits of CTLM could become a very important future clinical benefit especially now that many breast screening programs are under significant scrutiny."


http://www.businesswire.com/news/home/20120207006768/en/Imaging-Diagnostic-Remains-Committed-DOT-Shareholders

http://www.imds.com/news/2012/02

Mick Dodge

07/18/12 9:17 PM

#251149 RE: Nilbud #232260

VLNCQ LOOKING TO BOUNCE!!!

~ Blue ~

07/23/12 2:51 AM

#252313 RE: Nilbud #232260

DUSS(.0017) O/S 200 million Solid OTCQB company

Mick Dodge

07/26/12 9:18 PM

#253896 RE: Nilbud #232260

ICNB Chart

~ Blue ~

07/31/12 1:10 AM

#254947 RE: Nilbud #232260

DUSS(.0013) Fashion Co. Tiny float, DD with links

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

DUSS 228 million O/S, 179 million float

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77768858

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

1) Recent SEC filing 10Q: The Company has transitioned from being a manufacturer–wholesaler toward licensing its trademark

The Company moved operations to Vancouver in 2009.
In the spring of 2011 its design and head office moved to Los Angeles California where it now primarily designs apparel for its licensing partner, the Company continues to wholesale in very limited collections its luxury apparel to retail outlets and to individuals in Canada.

Our Apparel is designed in Los Angeles and samples manufactured by our licensing partner in North America.

The Company has transitioned from being a manufacturer–wholesaler toward licensing its trademark to other wholesalers in the primarily in the Canadian market, while promoting its marque.

The Company also entered into an agreement to purchase the trademark of a cosmetics line. Currently no sales, production or sampling of the cosmetic line has occurred or is planned.

Recent SEC filing, 10Q, March 31, 2012


PAGE F4

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8679182


2) The company added New Trademark: Open Sundaes in January 2012

the Company entered into an asset acquisition agreement (the “Agreement”) with Open Sundaes Ventures Ltd. (“Open Sundaes”) for the acquisition of certain assets relating to the business of the production and development of beauty and bath products including inventory, intellectual property and business knowhow.
The business of the production and development of beauty and bath products including inventory, intellectual property and business knowhow

On January 17, 2012, the Company issued the remaining 2,575,305 shares pursuant to the Agreement, fully satisfying the terms of the acquisition. As at the date of these financial statements, the Company has issued a total of 9,000,002 shares; 4,000,002 shares to the shareholders of Open Sundaes and 5,000,000 shares to a creditor of Open Sundaes.

SEC filing F-7 first paragraph.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8679182

3) Dussault Inc season 2 began on the Bio Channel!!! in January 2012 again.


http://www.rogersmediatv.ca/pr_detail.php?id=522
http://www.thebiographychannel.ca/tv/?Dussault

4) The company's New Director appointed on July 16, 2012
I guess She is well-known in Wallsteet.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8718721

5) DUSS profiled on July 18, 2012 here..

http://www.aimhighprofits.com/dussault-apparel-duss-stock-is-hotter-than-a-bikini-babe-15773


6) DUSS has low share structure down from .0185 to .0004 attracted some new investors as well.

~~~~~~~~~~~~~~~~ DETAIL DD LINK ~~~~~~~~~~~~~~~~~~~

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77743860

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


DUSS is very undervalued,solid stock with current share structure.


~Blue~[/b

BOS

07/31/12 8:22 AM

#255019 RE: Nilbud #232260

SBRH .0004 ~ Chart calling for bounce/continuation pattern!!

BOS ~ Calling for some Twitter loving :)

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77991478

~ Blue ~

08/02/12 1:04 AM

#255707 RE: Nilbud #232260

DUSS(.0013) low float, solid fashion stock DD with links

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

DUSS 228 million O/S, 179 million float

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77768858

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

1) Recent SEC filing 10Q: The Company has transitioned from being a manufacturer–wholesaler toward licensing its trademark

The Company moved operations to Vancouver in 2009.
In the spring of 2011 its design and head office moved to Los Angeles California where it now primarily designs apparel for its licensing partner, the Company continues to wholesale in very limited collections its luxury apparel to retail outlets and to individuals in Canada.

Our Apparel is designed in Los Angeles and samples manufactured by our licensing partner in North America.

The Company has transitioned from being a manufacturer–wholesaler toward licensing its trademark to other wholesalers in the primarily in the Canadian market, while promoting its marque.

The Company also entered into an agreement to purchase the trademark of a cosmetics line. Currently no sales, production or sampling of the cosmetic line has occurred or is planned.

Recent SEC filing, 10Q, March 31, 2012


PAGE F4

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8679182


2) The company added New Trademark: Open Sundaes in January 2012

the Company entered into an asset acquisition agreement (the “Agreement”) with Open Sundaes Ventures Ltd. (“Open Sundaes”) for the acquisition of certain assets relating to the business of the production and development of beauty and bath products including inventory, intellectual property and business knowhow.
The business of the production and development of beauty and bath products including inventory, intellectual property and business knowhow

On January 17, 2012, the Company issued the remaining 2,575,305 shares pursuant to the Agreement, fully satisfying the terms of the acquisition. As at the date of these financial statements, the Company has issued a total of 9,000,002 shares; 4,000,002 shares to the shareholders of Open Sundaes and 5,000,000 shares to a creditor of Open Sundaes.

SEC filing F-7 first paragraph.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8679182

3) Dussault Inc season 2 began on the Bio Channel!!! in January 2012 again.


http://www.rogersmediatv.ca/pr_detail.php?id=522
http://www.thebiographychannel.ca/tv/?Dussault

4) The company's New Director appointed on July 16, 2012
I guess She is well-known in Wallsteet.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8718721

5) DUSS profiled on July 18, 2012 here..

http://www.aimhighprofits.com/dussault-apparel-duss-stock-is-hotter-than-a-bikini-babe-15773


6) DUSS has low share structure down from .0185 to .0004 attracted some new investors as well.

~~~~~~~~~~~~~~~~ DETAIL DD LINK ~~~~~~~~~~~~~~~~~~~

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77743860

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


DUSS is very undervalued,solid stock with current share structure.


~Blue~

mick

08/03/12 2:18 AM

#256129 RE: Nilbud #232260

worth ah tweet? tweezer call, could be huge mover next wk. it could be best that ever happen here for shareholders.



Mick Dodge

08/06/12 7:41 PM

#257160 RE: Nilbud #232260

Compensated Awareness Post View Disclaimer
STOA Chart

ManicTrader

08/09/12 2:27 PM

#258022 RE: Nilbud #232260

I love cats but Jeez lmao

ManicTrader

08/09/12 2:35 PM

#258030 RE: Nilbud #232260

OLYMPICS ahhhh Been Watching alot of track and field- Love it

mick

08/10/12 9:29 PM

#258341 RE: Nilbud #232260

just back from tucson,az. all is good and safe trip. weather not bad.
*116

back to seeing what is good for us and as usual for findest pick'ins.

mick

08/10/12 9:35 PM

#258342 RE: Nilbud #232260

you gave this a tweet last wk...is there someting about this sleeper?

FCGD 0.0029 0.0013 81.25% 130,500 Chart, News, Stats, Board First Colombia Gold Corp.

from read'ins very good assets.

wouldn't take much to move this one in incubation.

mick

08/14/12 11:14 AM

#259271 RE: Nilbud #232260

tweet/could be huge winner; Abot Mining Company ABOT-sampling are huge...
this daytrade, wkly, midterm and longterm growth imho.
production cost / $88.00 per ton

OTC Market Tier OTC Pink Current

[-chart]www.otcmarkets.com/content/doc/otcm/tier/logo/small/20.png[/chart]

FORUM;
http://investorshub.advfn.com/Abot-Mining-Company-ABOT-1841/
Founded in 1957, Abot Mining Co. (ABOT.pk) is a US based mining company engaged in the exploration, discovery and production of precious and semi-precious metals and metal properties.

http://www.abotmining.com/index-1.html
Our project is in the Tecuala Mining District, which is considered a widely mineralized area and identified as a major deposit of gold and other minerals. The area around the Aztlan 8B has been extensively explored and is currently being mined by several known junior mining companies and geological institutions. We continue to evaluate adjacent claims to Aztlan 8B.

Mexico continues to be an attractive country for mining activities with a strong mining tradition, widespread communications and infrastructure, vast unexplored or underexplored areas, clear rules, security of tenure of mining concessions, political stability and no currency controls or restrictions on capital flows. We continue to evaluate our expansion in the region of Nayarit.

Aztlan 8B
Abot Mining along with Rising Star S.A. de C.V., a Mexican Corporation “Operating/JV Partner”, plans on developing its gold, silver and copper Aztlan 8B Mining Project “Aztlan 8B” in the State of Nayarit in the Tecuala Mining District on the west coast of Mexico. The Tecuala Mining District is considered a widely mineralized area and identified as a major deposit of gold and other minerals.

The claim covers 300 plus acres, and is within a few kilometers of the pueblo ' Paulo Blanco '. The area around the Aztlan 8B has been extensively explored and is currently being mined by several known junior mining companies and geological institutions. According to Rising Star, past surface trench testing by others revealed deposits of placer and epithermal gold deposits, where overall bulk sample feed grade ranged from 0.20 gm/t to 39.00 gm/t. These tests were conducted across outcroppings of silicified volcanic breccias.

To the north and east of the Project, Nayarit Gold, Inc., holds extensive mining claims and is conducting core drill evaluations. Few kilometers to the south of the Project is another successful mining company, Vane Minerals Group, which has the "El Diablito" claim that has average feed grade ranged from 2 g/T Au, 200 g/T Ag Source: www.vaneminerals.com. Further in the vicinity of the Project is US Gold, which has its El Gallo Project where only a limited amount of drilling has occurred on veins, but the results have been encouraging with measured and indicated resources of 39.8 million oz. of Ag and 550,000 oz. of Au (Source: http://www.usgold.com).

Off-Take Agreement
Abot Mining and its Mexican joint venture partner is pleased to announce that they have allocated up to 1,000 tons of Ore as an initial production test run. Subject to recovery rate results and refining cost from this production test run; Abot Mining shall increase the tonnage and frequency of the production.

Abot Mining has further received encouraging initial flotation engineering results, indicating a recovery value of 89.00% of the Au and Ag and show 2.51 ounces of Au and 19.00 ounces of Ag per metric ton. Based on these criteria, Abot Mining has contacted several mills and is in advance negotiation to finalize contract terms in order to define refining costs and to establish acceptable recovery rates for its Ore supply.

Other Claims
Subject to and conditioned upon availability of proper funding, Abot Mining plans to acquire various claims (gold and silver) in and around Aztlan 8 B area as recently concluded civil engineering work in February, 2012 on the Aztlan 8B Project further indicated that the mineral deposit may extend beyond the strike zone into an adjacent property to the south.

The Company has commenced preliminary negotiations with the property owner and is currently concluding its internal due diligence on documents provided by the property owner. If our preliminary analysis on this adjacent property is consistent in testing and surface sampling to the Aztlan 8B and deal terms meet our acquisition criteria, we shall immediately begin the process to add this property to our portfolio.


ABOT Security Details / Share Structure
http://www.otcmarkets.com/stock/ABOT/company-info
Shares Outstanding 814,337,072 a/o Jun 30, 2012
Float 153,352,366 a/o May 31, 2012
Authorized Shares 995,000,000 a/o May 31, 2012

Recent NewsABOT Mining provides production costs estimate for producing gold at Aztlan 8B in the Tecuala Mining District in Nayarit, Mexico

SHERMAN OAKS, Calif., June 12, 2012 /PRNewswire/ — ABOT Mining (Pink Sheets: ABOT.pk) is pleased to provide preliminary assessment on its estimated production costs for producing gold at Aztlan 8 B Property in the province of Nayarit, Mexico, which is located in the highly mineralized area known as the Tecuala Mining District.

Company’s operating partner has estimated production cost, at site level, per unit of production output to be up to $88.00 per ton including but not limited to cost associated with mining, transportation, milling & floatation and site administration. This cost does not include royalties, non-cash costs, corporate expenses, value addition of by-products, etc.

As previously stated, past surface trench testing by others on Aztlan 8B has revealed deposits of placer and epithermal gold deposits, where overall bulk sample feed grade ranged from 0.20 g/ton to 39.00 g/ton. Consequently, the cost estimate suggests that gold can be mined economically at the current gold prices and with average feed grade of 2 g/ton of Au and above

http://www.abotmining.com/index-4.html
http://www.abotmining.com/index-2.html

SEARCH;
http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=abot



2yr.- off grn, bb, ema50, ema100, vol., pps, cloud, ppo, macd/12%,
macd hist.


[-chart]stockcharts.com/c-sc/sc?s=abot&p=D&yr=1&mn=0&dy=0&i=p43184729579&a=140004738&r=8466[/chart]

2yr.- off grn, bb, ema50, ema100, vol., pps, cloud, ppo, macd/12%,
macd hist.
[-chart]stockcharts.com/c-sc/sc?s=abot&p=W&b=3&g=1&i=t54187326727&r=1340026534230[/chart]


mick

08/14/12 11:31 AM

#259276 RE: Nilbud #232260

tweet, bigtime news on cnbc today...AQLV 0.0022 0.0006 37.50% 1,308,480 Chart, News, Stats, Board Aqualiv Technologies, Inc.

showing how Our patented technology influences biological processes naturally and without chemical interaction. From increased crop yields to drug-free medicine, AquaLiv is providing innovative physics-based solutions to the world's largest problems.

Our Vision
A world without hunger, sickness, and pollution.

Our Mission
Feed and heal the world naturally through the development and application of bioinformation science.


cnbc/08-14-12 will be showing later in the day how the growing works.

more later.

Share Structure as of April 23rd 2012

Authorized Shares 1,000,000,000
Outstanding shares 502,605,319, as of June 14, 2012
Restricted 146,784,937
Float 271,855,164



2yr.- off grn, bb, ema50, ema100, vol., pps, cloud, ppo, macd/12%,
macd hist.


[-chart]stockcharts.com/c-sc/sc?s=aqlv&p=D&yr=1&mn=0&dy=0&i=p43184729579&a=140004738&r=8466[/chart]

2yr.- off grn, bb, ema50, ema100, vol., pps, cloud, ppo, macd/12%,
macd hist.
[-chart]stockcharts.com/c-sc/sc?s=aqlv&p=W&b=3&g=1&i=t54187326727&r=1340026534230[/chart]



mick

08/14/12 7:30 PM

#259395 RE: Nilbud #232260

me again my friend; aqlv
i was dream'ins. this is a good company though.

one said worth dime or more!

i have the link,

wrong company.

to fast to draw my stuff;

http://www.cnbc.com/id/48663511 mon is one with the seed.

Kooka_Duke

08/17/12 9:40 AM

#260367 RE: Nilbud #232260

""ROFLMFAO""..>>>>>""HLNT Blazinggggggggg Baby!

mick

08/23/12 3:02 PM

#262717 RE: Nilbud #232260

heads up tweet please! volume alert. tfzi r/m?

TFZI The Fight Zone, Inc. 19,945 9 minutes ago Media - Television Services

http://investorshub.advfn.com/boards/getboards.aspx?searchstr=tfzi

http://investorshub.advfn.com/The-Fight-Zone-Inc-TFZI-13636/

part two;
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=78834416
TOUCAN Thursday, August 23, 2012 12:39:46 AM

$TFZI Billion $$ Merger in the WORKS?

http://www.zoominfo.com/people/Frear_David_30953076.aspx

Colliers International Ltd
http://www.zoominfo.com/company/Colliers+International+Ltd-37244484

Company Background & Description

Revenue: $500 mil. - $1 bil.
Employees: 1,000 - 5,000
Industry: Real Estate
SIC Codes: Real Estate Agents and Managers
Products and Services: real estate , property , treasure valley commercial real estate brokerage , investment sales , multi-disciplinary valuation

Company Description: Colliers International is a global affiliation of independently owned commercial real estate firms. The organization's 10,171 employees span the world in 267 offices in 57 countries. On a worldwide basis, Colliers manages 672,945,918 square feet, and has revenue of $US 1,620,958,349.





OCKHAM'S RAZOR

08/28/12 2:13 PM

#264484 RE: Nilbud #232260

WEEKLY CHARTS ON AQLV, CCTC, INTK, WTAR looking interesting here..imo

BIGUPS

08/29/12 1:38 PM

#264879 RE: Nilbud #232260

hey can you give a big tweet out for JFGI this thing has been running great and is sooo thin!!!

ManicTrader

09/04/12 1:10 PM

#266951 RE: Nilbud #232260

Flip Flops or Crox?? lmao